Generic rivaroxaban (once daily) and generic apixaban (twice daily) are joint best-value DOACS for patients commencing treatment for atrial fibrillation

Generic rivaroxaban (once daily) and generic apixaban (twice daily) are joint best-value DOACS for patients commencing treatment for atrial fibrillation

Papulopustular rosacea - discontinue if no improvement after 1 month

Be aware of variations of indications between brands

Hydroxyzine is favoured by the dermatologists for its sedating effects.

Hydroxyzine is favoured by the dermatologists for its sedating effects.

Adex gel is accepted onto the formulary as an option for patients only following poor response from other first / second line formulary choices

May be prescribed on the recommendation of a specialist:

May be initiated on the advice of palliative care specialist

Apraclonidine 1% and 0.5% can be prescribed in primary care after Ophthalmic Consultant initiation. The 1% strength is sometimes used as complex glaucoma management in patients sensitive to preserved eye drops .

May be considered for use in the management of fatigue in patients with multiple sclerosis, as per NG220

RCHT Renal Team prefers Adoport brand of Tacrolimus

RCHT Renal Team prefers Adoport brand of Tacrolimus

Product discontinued with stock exhaustion expected September 2025

Apraclonidine 1% and 0.5% can be prescribed in primary care after Ophthalmic Consultant initiation. The 1% strength is sometimes used as complex glaucoma management in patients sensitive to preserved eye drops .

RCHT Renal Team prefers Adoport brand of Tacrolimus

Aripiprazole prolonged release suspension for injection (Abilify Maintena) is accepted onto the formulary. Patients have to be stabilised on this depot injection for up to 3 months prior to CPFT requesting GPs to take over prescribing responsibility.

Antacid and oxetacaine suspension contains a local anaesthetic and is useful post radiotherapy and for topical analgesia in very severe painful oesophagitis.